MethodSense Releases 2026 Regulatory Outlook for MedTech Industry
-
MethodSense Releases 2026 Regulatory Outlook for MedTech Industry
What regulatory shifts in AI, cybersecurity, digital submissions, and capital strategy mean for your success in 2026… MORRISVILLE, NC – March 12, 2026, MethodSense, Inc. today announced the release of its 2026 Regulatory Outlook, providing MedTech innovators, investors, and strategic partners with forward-looking guidance on the regulatory forces shaping the year ahead. As medical device…
-
MethodSense Corporate Backgrounder
The Corporate Backgrounder provides an overview of MethodSense, who we are, what we do, and how we help medical technology companies achieve regulatory and commercial success. It highlights our expertise in regulatory strategy, quality systems, and capital alignment, along with the role of the LuminLogic platform in supporting successful product development and market authorization.
-
MethodSense Launches Capital & Investment Strategy Advisory for the MedTech Sector
New practice aligns regulatory intelligence with fundable growth and confident capital deployment… MORRISVILLE, NC – March 10, 2026, MethodSense, a regulatory and quality advisory firm serving the medical device industry, today announced the launch of its Capital & Investment Strategy advisory practice, designed to align regulatory intelligence with capital decisions across the MedTech lifecycle. As…
-
MethodSense Receives Global Reach Award for Trade Excellence from NC Governor Stein and EDPNC
Honored for advancing North Carolina’s global life sciences presence through regulatory intelligence and compliance technology… MORRISVILLE, NC – March 05, 2026, MethodSense, a North Carolina–based regulatory and quality advisory firm serving the global life sciences industry, has been recognized for Export Trade Excellence by Josh Stein, in partnership with the Economic Development Partnership of North…
-
MethodSense Supports Ulrich Medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector System
Collaboration underscores MethodSense’s role in accelerating market access and regulatory confidence for advanced medical device innovations… Morrisville, NC, January 15, 2026, MethodSense, Inc. a leading regulatory and quality consulting firm for the medical device industry, announced today that its client Ulrich Medical has received its fourth FDA clearance for the Ulrich Medical CT Motion Injector,…
-
MethodSense Announces Growth Plans to Meet the Demands of a Rapidly Evolving Regulatory Landscape
With new leadership, platform innovation, and an AI-era focus, MethodSense is scaling its service offerings and software platform to help MedTech innovators meet global regulatory demands. Morrisville, NC – July 23, 2025, MethodSense, a leading regulatory and quality consulting firm for the life sciences industry, today announced a bold new phase of growth, propelled by…